vs
美泰（MAT）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
美泰的季度营收约是West Pharmaceutical Services的1.1倍（$862.2M vs $805.0M），West Pharmaceutical Services净利率更高（16.4% vs 7.1%，领先9.3%），West Pharmaceutical Services同比增速更快（7.5% vs 4.3%），West Pharmaceutical Services自由现金流更多（$175.0M vs $-88.1M），过去两年West Pharmaceutical Services的营收复合增速更高（7.6% vs -10.6%）
美泰是美国知名玩具及娱乐企业，旗下影视制作部门美泰影业运营时间为2018年9月6日至2025年6月2日。其前身为2013年10月16日成立的美泰Playground Productions，更早可追溯至美泰娱乐、美泰工作室等集团原有娱乐业务品牌。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
MAT vs WST — 直观对比
营收规模更大
MAT
是对方的1.1倍
$805.0M
营收增速更快
WST
高出3.2%
4.3%
净利率更高
WST
高出9.3%
7.1%
自由现金流更多
WST
多$263.1M
$-88.1M
两年增速更快
WST
近两年复合增速
-10.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $862.2M | $805.0M |
| 净利润 | $61.0M | $132.1M |
| 毛利率 | 44.9% | 37.8% |
| 营业利润率 | — | 19.5% |
| 净利率 | 7.1% | 16.4% |
| 营收同比 | 4.3% | 7.5% |
| 净利润同比 | 251.4% | 1.5% |
| 每股收益（稀释后） | $0.20 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATWST
| Q1 26 | $862.2M | — | ||
| Q4 25 | $1.8B | $805.0M | ||
| Q3 25 | $1.7B | $804.6M | ||
| Q2 25 | $1.0B | $766.5M | ||
| Q1 25 | $826.6M | $698.0M | ||
| Q4 24 | $1.6B | $748.8M | ||
| Q3 24 | $1.8B | $746.9M | ||
| Q2 24 | $1.1B | $702.1M |
净利润MATWST
| Q1 26 | $61.0M | — | ||
| Q4 25 | $106.2M | $132.1M | ||
| Q3 25 | $278.4M | $140.0M | ||
| Q2 25 | $53.4M | $131.8M | ||
| Q1 25 | $-40.3M | $89.8M | ||
| Q4 24 | $140.9M | $130.1M | ||
| Q3 24 | $372.4M | $136.0M | ||
| Q2 24 | $56.9M | $111.3M |
毛利率MATWST
| Q1 26 | 44.9% | — | ||
| Q4 25 | 45.9% | 37.8% | ||
| Q3 25 | 50.0% | 36.6% | ||
| Q2 25 | 50.9% | 35.7% | ||
| Q1 25 | 49.4% | 33.2% | ||
| Q4 24 | 50.7% | 36.5% | ||
| Q3 24 | 53.1% | 35.4% | ||
| Q2 24 | 49.2% | 32.8% |
营业利润率MATWST
| Q1 26 | — | — | ||
| Q4 25 | 8.0% | 19.5% | ||
| Q3 25 | 21.9% | 20.8% | ||
| Q2 25 | 7.7% | 20.1% | ||
| Q1 25 | -6.4% | 15.3% | ||
| Q4 24 | 9.6% | 21.3% | ||
| Q3 24 | 26.5% | 21.6% | ||
| Q2 24 | 7.7% | 18.0% |
净利率MATWST
| Q1 26 | 7.1% | — | ||
| Q4 25 | 6.0% | 16.4% | ||
| Q3 25 | 16.0% | 17.4% | ||
| Q2 25 | 5.2% | 17.2% | ||
| Q1 25 | -4.9% | 12.9% | ||
| Q4 24 | 8.6% | 17.4% | ||
| Q3 24 | 20.2% | 18.2% | ||
| Q2 24 | 5.3% | 15.9% |
每股收益（稀释后）MATWST
| Q1 26 | $0.20 | — | ||
| Q4 25 | $0.32 | $1.82 | ||
| Q3 25 | $0.88 | $1.92 | ||
| Q2 25 | $0.16 | $1.82 | ||
| Q1 25 | $-0.12 | $1.23 | ||
| Q4 24 | $0.40 | $1.78 | ||
| Q3 24 | $1.09 | $1.85 | ||
| Q2 24 | $0.17 | $1.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $866.0M | $791.3M |
| 总债务越低越好 | $2.3B | $202.8M |
| 股东权益账面价值 | $2.1B | $3.2B |
| 总资产 | $6.3B | $4.3B |
| 负债/权益比越低杠杆越低 | 1.11× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资MATWST
| Q1 26 | $866.0M | — | ||
| Q4 25 | $1.2B | $791.3M | ||
| Q3 25 | $691.9M | $628.5M | ||
| Q2 25 | $870.5M | $509.7M | ||
| Q1 25 | $1.2B | $404.2M | ||
| Q4 24 | $1.4B | $484.6M | ||
| Q3 24 | $723.5M | $490.9M | ||
| Q2 24 | $722.4M | $446.2M |
总债务MATWST
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | $202.8M | ||
| Q3 25 | $2.3B | $202.7M | ||
| Q2 25 | $2.3B | $202.6M | ||
| Q1 25 | $2.3B | $202.6M | ||
| Q4 24 | $2.3B | $202.6M | ||
| Q3 24 | $2.3B | $202.6M | ||
| Q2 24 | $2.3B | $205.8M |
股东权益MATWST
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.2B | $3.2B | ||
| Q3 25 | $2.3B | $3.1B | ||
| Q2 25 | $2.2B | $2.9B | ||
| Q1 25 | $2.1B | $2.7B | ||
| Q4 24 | $2.3B | $2.7B | ||
| Q3 24 | $2.3B | $2.8B | ||
| Q2 24 | $2.0B | $2.6B |
总资产MATWST
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.6B | $4.3B | ||
| Q3 25 | $6.6B | $4.1B | ||
| Q2 25 | $6.2B | $4.0B | ||
| Q1 25 | $6.2B | $3.6B | ||
| Q4 24 | $6.5B | $3.6B | ||
| Q3 24 | $6.5B | $3.7B | ||
| Q2 24 | $5.9B | $3.5B |
负债/权益比MATWST
| Q1 26 | 1.11× | — | ||
| Q4 25 | 1.04× | 0.06× | ||
| Q3 25 | 1.03× | 0.07× | ||
| Q2 25 | 1.08× | 0.07× | ||
| Q1 25 | 1.10× | 0.08× | ||
| Q4 24 | 1.03× | 0.08× | ||
| Q3 24 | 1.01× | 0.07× | ||
| Q2 24 | 1.18× | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $251.1M |
| 自由现金流经营现金流 - 资本支出 | $-88.1M | $175.0M |
| 自由现金流率自由现金流/营收 | -10.2% | 21.7% |
| 资本支出强度资本支出/营收 | 7.6% | 9.5% |
| 现金转化率经营现金流/净利润 | — | 1.90× |
| 过去12个月自由现金流最近4个季度 | — | $468.9M |
8季度趋势，按日历期对齐
经营现金流MATWST
| Q1 26 | — | — | ||
| Q4 25 | $796.6M | $251.1M | ||
| Q3 25 | $72.0M | $197.2M | ||
| Q2 25 | $-300.1M | $177.1M | ||
| Q1 25 | $24.8M | $129.4M | ||
| Q4 24 | $862.1M | $190.1M | ||
| Q3 24 | $155.8M | $180.1M | ||
| Q2 24 | $-252.9M | $165.0M |
自由现金流MATWST
| Q1 26 | $-88.1M | — | ||
| Q4 25 | — | $175.0M | ||
| Q3 25 | — | $133.9M | ||
| Q2 25 | — | $101.9M | ||
| Q1 25 | — | $58.1M | ||
| Q4 24 | — | $85.2M | ||
| Q3 24 | — | $98.8M | ||
| Q2 24 | — | $64.8M |
自由现金流率MATWST
| Q1 26 | -10.2% | — | ||
| Q4 25 | — | 21.7% | ||
| Q3 25 | — | 16.6% | ||
| Q2 25 | — | 13.3% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 9.2% |
资本支出强度MATWST
| Q1 26 | 7.6% | — | ||
| Q4 25 | — | 9.5% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 9.8% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 10.9% | ||
| Q2 24 | — | 14.3% |
现金转化率MATWST
| Q1 26 | — | — | ||
| Q4 25 | 7.50× | 1.90× | ||
| Q3 25 | 0.26× | 1.41× | ||
| Q2 25 | -5.62× | 1.34× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | 6.12× | 1.46× | ||
| Q3 24 | 0.42× | 1.32× | ||
| Q2 24 | -4.45× | 1.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MAT
暂无分部数据
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
